B. Riley raised the firm’s price target on Diversified Healthcare Trust to $6 from $5 and keeps a Buy rating on the shares. The company’s Q2 results were in-line, driven by expected senior housing improvement, but there was also “material compelling news that should help drive the shares higher,” the analyst tells investors in a research note. The firm says the senior housing recovery is unfolding as expected.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DHC:
